Fortrea Holdings Inc. FTRE
18.55 USD -1.60 (-7.94%)
Regular-session close
18.55 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
18.30 Day range 20.52
8.55 52-week range 26.16
- YTD
- +7.54%
- 1 year
- +84.76%
News
seekingalpha.com Fortrea: A Promising Turnaround At An Attractive Valuation Fortrea Holdings (FTRE) receives a buy rating due to operational restructuring, improving profitability, and a positive new orders trend despite ongoing revenue decline. FTRE's Q3 2026 results show…benzinga.com TD Cowen Maintains Buy on Fortrea Holdings, Raises Price Target to $26 TD Cowen analyst Charles Rhyee maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises the price target from $23 to $26.
benzinga.com Citigroup Maintains Buy on Fortrea Holdings, Raises Price Target to $27 Citigroup analyst Albert Hu maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises the price target from $22 to $27.
benzinga.com Truist Securities Maintains Buy on Fortrea Holdings, Raises Price Target to $29 Truist Securities analyst Jailendra Singh maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises the price target from $26 to $29.
benzinga.com Barclays Maintains Overweight on Fortrea Holdings, Raises Price Target to $26 Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Overweight and raises the price target from $23 to $26.
benzinga.com Evercore ISI Group Maintains Outperform on Fortrea Holdings, Raises Price Target to $28 Evercore ISI Group analyst Elizabeth Anderson maintains Fortrea Holdings (NASDAQ:FTRE) with a Outperform and raises the price target from $25 to $28.
benzinga.com Fortrea Holdings Q3 2026 Earnings Call Transcript Fortrea Holdings (NASDAQ:FTRE) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com Fortrea Holdings Raises FY2026 Sales Guidance from $2.620B-$2.690B to $2.665B-$2.690B vs $2.663B Est Fortrea Holdings (NASDAQ:FTRE) raises FY2026 sales outlook from $2.620 billion-$2.690 billion to $2.665 billion-$2.690 billion vs $2.663 billion estimate.
benzinga.com Fortrea Holdings Q3 Adj. EPS $0.28 Beats $0.22 Estimate, Sales $691.500M Beat $669.951M Estimate Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.22 by 27.27 percent. This is a 133.33 percent increase over earnings of…
benzinga.com Fortrea And Omico Collaborate To Accelerate Precision Oncology Research By Helping Connect Cancer Patients To Biomarker-Matched Clinical Trials HighlightsCollaboration aims to accelerate precision oncology research in AustraliaCombines Fortrea’s experience in oncology clinical trials with Omico’s Precision Oncology Screening Platform…
benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…benzinga.com UBS Maintains Neutral on Fortrea Holdings, Raises Price Target to $24 UBS analyst Kevin Caliendo maintains Fortrea Holdings (NASDAQ:FTRE) with a Neutral and raises the price target from $22 to $24.
